Cryoablation of Bone Metastases From Endocrine Tumors
Cone-beam Computed Tomography Guided Percutaneous Cryoablation of Bone Metastases From Endocrine Tumors
Sponsor: Instituto do Cancer do Estado de São Paulo
Terminated
The study achieved n=17 participants (56.6% of the initial proposition) with a mean = 18 months follow-up. All patients completed 12 months follow-up or deceased. We chose to terminate and publish the data available.
Other terminated trials from Instituto do Cancer do Estado de São Paulo
- COVID · Phase PHASE2 · Jun 2022
- Plasmacytoma · Phase PHASE2 · Mar 2022
- Gastrointestinal Hemorrhage · Phase NA · Aug 2020
- Rectal Cancer · Phase NA · Apr 2020
- Solid Tumor · Phase PHASE2 · Sep 2019
See all terminations from Instituto do Cancer do Estado de São Paulo
Other Adrenal Neoplasm trials with similar outcome
A NA clinical study on Adrenal Neoplasm and Bone Metastases, this trial is terminated or withdrawn. The trial is conducted by Instituto do Cancer do Estado de São Paulo and has accumulated 10 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Aug 2023 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Sep 2022 — Aug 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2022 — Sep 2022 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — May 2022 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Aug 2020 [monthly]
Recruiting NA
-
Sep 2019 — Feb 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2019 — Sep 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto do Cancer do Estado de São Paulo
- University of Sao Paulo General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .